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ABSTRACT Drug-membrane interactions are well known but poorly understood. Here we describe dual measurements of
membrane thickness change and membrane area change due to the binding of the amphipathic drug curcumin. The combined
results allowed us to analyze the binding states of a drug to lipid bilayers, one on the water-membrane interface and another in the
hydrocarbon region of the bilayer. The transition between the two states is strongly affected by the elastic energy of membrane
thinning (or, equivalently, area stretching) caused by interfacial binding. The data arewell described by a two-statemodel including
this elastic energy. The binding of curcumin follows a common pattern of amphipathic peptides binding tomembranes, suggesting
that the binding states of curcumin are typical for amphipathic drugs.
INTRODUCTION
The lipid matrix, or the lipid bilayer, of cell membranes is a
natural binding site for amphipathic molecules, including
proteins, organic molecules such as drugs, detergents, and
others. However the biological effect of drug-membrane in-
teractions (1) is unclear. For example, if drugs must diffuse
through membranes to bind to speciﬁc protein targets, then
binding to the membrane may cause a secondary effect dis-
tinct from that of the drug-protein interaction. Whether the
membrane-binding produces desirable or undesirable effects,
it is important to understand the effect of drug binding to lipid
bilayers, since there are concrete examples that a change of
the physical state of the lipid bilayer can affect the functions
of embedded proteins (2,3). It is well recognized that am-
phipathic molecules can bind to the membrane-water inter-
face or intercalate into the nonpolar chain region (1). As far as
we know, the energetics of these two binding states of drugs
and their effects on lipid bilayers have not been analyzed. In
this work we show that the dual measurements of both the
membrane thickness and the membrane area changes due to
drug binding allow such analyses.
Curcumin is an example of amphipathic drugs that bind to
cell membranes (4,5). This yellow spice has long been re-
ported to be biologically active, most often as having anti-
inﬂammatory, antiangiogenic, antioxidant, wound-healing,
and anticancer effects (6,7). However its efﬁcacy has been a
subject of controversy (8), and its mechanism of action re-
mains obscure. In particular, curcumin modulates the func-
tion and expression of a wide range of structurally and
functionally unrelated membrane proteins, which suggests
that curcumin might alter membrane protein function by
modulating the properties of the host lipid bilayer (2). In a
recent work, we reported a nonlinear thinning effect on lipid
bilayers caused by curcumin binding (9). This was found by
an x-ray diffraction measurement of the bilayer thickness as
a function of curcumin content. The thinning result allowed
us to explain the effect of curcumin on the lifetime of the
gramicidin single channel (2,9). To gain a more complete
understanding of the curcumin-membrane interactions, we
report here a systematic measurement of the responses of
individual giant unilamellar vesicles (GUVs) to the binding
of curcumin from solution. The GUV experiment measured
the change of the membrane area due to curcumin binding, to
be compared with the corresponding membrane thinning.
From these two results, we are able to deduce the binding
states of curcumin in lipid bilayers. We construct a simple
two-state model assuming that there are two distinct bound
states for curcumin—one at the interface and another in the
hydrocarbon chain region. The energy of the interfacial
binding state includes the elastic energy of the membrane
thinning. This simple model reproduces the experimental
data.
The choice of the two experimental methods was in part
motivated by the desire to answer these questions: Is an effect
on membranes measured in a multilamellar preparation, as
used in x-ray diffraction experiments, reproducible by a
measurement of a single membrane in solution, as in a GUV
experiment? Are the two measurements quantitatively com-
patible? These questions are afﬁrmatively answered by the
agreement between the membrane-thinning measured in
multilamellae and the membrane area increase measured in
GUVs. The quantitative analysis of these two sets of data
provides an example for applying similar analyses to other
membrane-binding molecules.
We found that the binding behavior of curcumin follows
the same pattern as more hydrophilic amphipathic peptides.
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This implies that the binding states of curcumin are typical of
amphipathic drugs.
MATERIALS AND METHODS
Materials
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (Rh-
DOPE) were purchased from Avanti Polar Lipids (Alabaster, AL). 3,39-
dioctadecyloxacarbocyanine perchlorate (DiO)was from Invitrogen (Carlsbad,
CA). Curcumin (product number 28260), HEPES (product number H3375),
bovine serum albumin (BSA) (product number A9418), and dimethyl sulf-
oxide (DMSO) were from Sigma-Aldrich (St. Louis, MO). All materials
were used as delivered.
Sample preparation
Curcumin (Fig. 1 a) can be dissolved in water by ﬁrst dissolving it in DMSO.
But the water solubility and the molecular stability of curcumin is strongly
pH dependent. The aqueous solubility decreases as pH decreases below 7,
but the molecule degrades as pH increases above 7 (10). Therefore a buffer
solution of 20 mMHEPESwas used to maintain the solution at pH 7. Optical
spectroscopy was employed to calibrate the curcumin concentration and to
monitor its molecular integrity (10). In our previous study (9), we showed
that at pH 7 the solubility limit for curcumin is;25 mM. Curcumin was ﬁrst
dissolved in DMSO at 19 mM and then diluted with sucrose/HEPES solution
to desired concentrations (,25 mM). Almost all previous GUV studies by
the aspiration method were performed in 100–200 mM sucrose solutions
(11,12). The curcumin solutions were kept in the dark as much as possible
because curcumin is sensitive to light (13). Also, curcumin adsorbed to the
walls of containers, often 5%–20%, depending on the material and the sur-
face/volume ratio of the container. The loss of curcumin to the container wall
at each step of solution transfer was carefully monitored by a spectral mea-
surement (9).We also took into account the fraction of curcumin adhered to the
wall of the experimental chamber. We estimated the uncertainty of the cur-
cumin concentration in the experimental chamber to be approximately610%.
GUV experiment
GUVs were produced in 200 mM sucrose solution by the electroformation
method (14). DOPC and a 0.4% molar ratio of a headgroup ﬂuorescent lipid
were codissolved in chloroform. A ﬂuorescent lipid was added to enhance the
contrast of the GUV boundary. We found no difference between the two
ﬂuorescent lipids Rh-DOPE and DiO. The lipid solution was dried onto two
platinum electrodes. After drying under vacuum, the electrodes were placed
5 mm apart in a chamber ﬁlled with 200 mM sucrose solution. We applied
1.5 V alternating current at a frequency of 10 Hz across the electrodes for
10min. Then the voltage was changed to 3 V, and the frequency was adjusted
to 10Hz for 40min, followed by 3Hz for 15min, 1 Hz for 10min, and 0.5 Hz
for 30 min. This electroformation method has been shown to produce uni-
lamellar large vesicles (14). The vesicle suspension was then gently collected
in a glass vial. The vesicles were used within 24 h of production.
To perform the GUV experiment, the vesicles were ﬁrst transferred to a
control chamber containing an ;180 mM sucrose and 20 mM HEPES so-
lution. The osmolality of every solution used in the GUV experiment was
measured by a Wescor Model 5520 dew point Osmometer (Wescor, Logan,
UT). The osmolality of the solution in the control chamber was the same as
the 200 mM sucrose solution inside the GUVs. A micropipette (of inner
radius 8–10mm) was used to hold a chosen GUV (of 25–35mm in radius) by
aspiration at a constant negative pressure (which created a membrane tension
of 0.5 dyn/cm (15)). Before use, the micropipette was coated with 0.5% BSA
to neutralize the charge on the bare glass surface (16) and washed extensively
by 200 mM sucrose solution. The tail end of the aspiration pipette was
connected to a pressure control system constructed similarly to a setup de-
scribed by Fygenson et al. (17). A syringe was used to create a negative
pressure inside the micropipette, which was referenced to the atmospheric
pressure by a water-ﬁlled U tube. The value of the negative pressure was
monitored via a manometerMKS Baratron 223 (Andover, MA) and recorded
for postexperimental inspection. The curcumin experiment was performed
by transferring the aspirated GUV to an observation chamber that contained a
curcumin/sucrose/HEPES solution (see schematic in Fig. 1 b). The observation
chamber was set side-by-side with the control chamber, separated by ;1 cm.
A transfer pipette (inner diameter 0.75 mm) ﬁlled with the control solution was
inserted from the opposite side of the aspiration pipette through the observation
chamber into the control chamber. The aspiration pipette and the transfer
pipette were held separately by motor-driven micromanipulators Narishige
MM-188NE (East Meadow, NY). The aspirated GUV was inserted;0.7 mm
into the transfer pipette in the control chamber. By moving the microscope
stage, the aspirated GUV in the transfer pipette was moved from the control
chamber to the observation chamber. Then the transfer pipette was swiftly
moved away so that the GUV was exposed to the curcumin/sucrose/HEPES
solution (marked as t ¼ 0).
If the observation chamber contained a sucrose/HEPES (without cur-
cumin) solution isotonic to a 200 mM sucrose solution, the GUV remained
unchanged, as expected. When curcumin was present in the solution of the
observation chamber, the vesicle projection in the micropipette immediately
increased its length and reached an equilibrium length within ;100 s.
Thereafter the projection length remained unchanged. The video image of the
process was captured by a Nikon NS-5 MC camera (Nikon, Tokyo, Japan)
(Fig. 2). The response of GUVs indicated that the outer and inner leaﬂets of
the bilayers changed their areas together, implying that the same amount of
curcumin bound to both leaﬂets; otherwise there would be an areal imbalance
between the outer and inner leaﬂets that was not observed. On a number of
runs, we used glucose instead of sucrose in the observation chamber to
measure the phase contrast between the inside and outside of the GUV and
detected no change in the contrast during the entire process. This implied that
there was no content exchange between the inside and outside of the GUV.
We assumed that there was no change in the vesicle volume during curcumin
binding. Then the increase of the vesicle projection in the micropipette can be
FIGURE 1 (a) Chemical structure of curcumin. (b) Schematic of the GUV
experiment (see text). (1) An aspirated GUV was inserted;0.7 mm into the
transfer pipette in the control chamber. (2) The aspirated GUV in the transfer
pipette was moved from the control chamber to the observation chamber. (3)
Then the transfer pipette was swiftly moved away so that the GUV was
exposed to the curcumin/sucrose/HEPES solution (marked as t ¼ 0).
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translated to an increase in the membrane area by the geometric relation (15)
DA ¼ 2pRpð1 Rp=RvÞDLp; where Rp and Rv are radii of the pipette and
vesicle, and Lp is the projection length (Fig. 2). All the values of Rp; Rv; and
Lp were carefully measured and analyzed by using the Nikon NIS-Elements
BR 2.30 software. To normalize the area changes for vesicles of different
sizes,DLp was converted to the fractional change of vesicle areaDA/A plotted
as a function of time (see below). To minimize the osmolality change due to
evaporation, solutions in the chambers were changed frequently (approxi-
mately every 15 min).
Effect of DMSO
DMSO was used to solubilize curcumin in an aqueous solution of pH 7. The
amount of DMSO used was proportional to the curcumin concentration.
The highest curcumin concentration in our experiment was 13.5 mM (after
the calibration for the losses to the container walls mentioned above), and its
corresponding DMSO content was 0.16% (or 20 mM). DMSO has been
shown to have no effect on lipid bilayer properties at such low concentra-
tions. Longo et al. (11) showed that in the presence of 0.5% DMSO, the
rupture tensions for lipid vesicles were the same as without DMSO. Hwang
et al. (18) showed that DMSO at 0.8% did not affect the single channel
lifetime of gramicidin. However, we found that DMSO presented a problem
for the osmotic balance in a GUV experiment. For example when we used a
solution of sucrose/HEPES and 0.16% DMSO in the observation chamber
that was measured to have the same osmolality as the 200 mM sucrose so-
lution inside the GUV, we found the vesicle projection length diminished and
the GUV burst, indicating a tonicity imbalance. Apparently the GUV
swelled, since, at constant vesicle surface area, the vesicle volume changeDV
is related to the projection length change by DV ¼ pRpðRv  RpÞDLp: The
most reasonable explanation is that the lipid bilayer is permeable to DMSO;
therefore, DMSO did not contribute to the tonicity (the effective osmolality
with respect to the membrane). This made the osmotic pressure outside the
GUV lower than inside, hence causing swelling. However, if we added
0.16% DMSO to a sucrose/HEPES solution which was already isotonic to
200 mM sucrose solution inside the GUV and used it in the observation
chamber, the vesicle projection length would increase slightly, indicating an
outﬂow of water from the GUV. Apparently DMSO contributed slightly to
the tonicity, not entirely consistent with DMSO being a permeant solute. This
was also observed by Longo et al. (11).
Curcumin experiment
Since the interaction between DMSO and curcumin might alter the tonicity
contribution by DMSO, we were not conﬁdent that the effect of DMSO is
correctable by a background subtraction (11). Therefore, we performed the
curcumin experiment in two ways to measure the upper and lower limits of
the curcumin effect on the lipid bilayer. In the ﬁrst experiment, the obser-
vation chamber contained a sucrose/HEPES/curcumin/DMSO solution of
various curcumin concentrations. Each solution was measured to have the
same osmolality as the 200 mM sucrose solution. The GUV response was
recorded and plotted as DA/A vs. time in Fig. 3. In this case, the vesicle
volume would somewhat increase and make the DLp somewhat smaller than
the pure curcumin effect. Therefore the measurement represented a lower
limit of the curcumin effect.
In the second experiment, the observation chamber contained a sucrose/
HEPES solution that was measured to have the same osmolality as 200 mM
sucrose solution. Then the appropriate amount of curcumin/DMSO was
added to obtain the desired curcumin concentration. The GUV response was
recorded and plotted as DA/A versus time in Fig. 3. In this case, the vesicle
volume would somewhat decrease and make the DLp somewhat longer than
the pure curcumin effect. Therefore the measurement represented an upper
limit of the curcumin effect.
DISCUSSION
A lipid bilayer responds to molecular binding by changing its
thickness and its surface area. If an amphipathic molecule
binds to the water-membrane interface, it necessarily inserts
between lipid headgroups and causes an interfacial area ex-
pansion. An interfacial area expansion will cause membrane
thinning, due to the very small volume compressibility of
hydrocarbon chains (19). The relation between the thickness
FIGURE 2 Sequential videomicrographs of aGUVheld un-
der a small constant pressure exposed to 8.96 mM curcumin
solution. Lp, Rp, and Rv are indicated.
FIGURE 3 Time sequence of frac-
tional area changes of individual DOPC
GUVs exposed to various concentrations
of curcumin: 13.5 mM (green), 8.96 mM
(yellow), 4.49mM(blue), 1.35mM(red).
Different symbols represent different
runs. (Left) For each run, the osmolality
of the solution in the observation cham-
ber, including curcumin/DMSO, was
made the same as the 200 mM sucrose
solution inside the GUV. (Right) For
each run, the curcumin/DMSO solution
was added to a sucrose/HEPES solution
that had the same osmolality as the 200
mM sucrose solution inside the GUV.
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change and the area change due to an interfacial molecular
binding is simplyDh=h ¼ DA=A;where h is the thickness of
the hydrocarbon region and A is the surface area of the lipid
bilayer. On the other hand, if a molecule intercalates into the
hydrocarbon chain region, it would certainly expand the
membrane area, but it might not affect themembrane thickness.
Membrane thinning
The thickness of a phospholipid bilayer can be measured by
its phosphate-to-phosphate distance (PtP) across the bilayer.
The PtP of DOPC bilayers was previously measured by x-ray
diffraction as a function of its curcumin content (9) and is
reproduced in Fig. 4. The data show that the initial binding
of curcumin has a large thinning effect up to the bound
curcumin/lipid ratio of ;0.032, but the effect becomes
considerably smaller upon further binding. Qualitatively, this
indicates that there is one low-energy binding state that
causes thinning and a higher energy binding state that has
little thinning effect.
We consider the low energy state ﬁrst. To the ﬁrst few
amphipathic molecules approaching a lipid bilayer, the in-
terface, rather than the nonpolar chain region, is expected to
be the lowest energy binding site. This has been proven for
amphipathic peptides (mostly antimicrobial peptides (20)),
which in all cases initially bind to the interface of lipid bi-
layers (21–24) by hydrophobic interactions (25). We will
call this interfacial binding the S state and denote the area
expansion per molecule by AS. We know that to a very good
approximation, the thickness of the hydrocarbon region is
h  PtP 10 A˚; or PtPminus twice the length of the glycerol
region (from the phosphate to the ﬁrst methylene of the hy-
drocarbon chains) for pure lipid bilayers as well as for bila-
yers containing bound molecules (9). Let Cb be the total
number of curcumin molecules bound to a bilayer of L lipid
molecules. If the number of curcumin molecules in the S state
is N(S), then we have the membrane thinning due to the
curcumin molecules bound to the S state:
Dh=h ¼ DA=A ¼ ASNðSÞ=ALL; (1)
where AL is the cross section area for each lipid molecule in
the bilayer.
Another possible binding site is the interior of the hydro-
carbon chain region, into which a curcumin molecule may
insert and stay bound. We assume that this is the higher en-
ergy state (the I state) for curcumin.We assume that the I state
will cause a membrane area expansion, AI, per molecule but
will not cause membrane thinning. Then the membrane
thinning by curcumin binding is given by Eq. 1.
To express N(S)/L in terms of the curcumin/lipid ratio Cb/L,
we need to know the energy difference between the S state
and the I state; and we believe that the crucial idea is that the
elastic energy of membrane thinning must be included in the
energy level of the S state. This energy can be derived as
follows (26): A fractional area expansion DA/A is a strain
whose corresponding stress is the monolayer tension s ¼
ðKa=2ÞDA=A; where Ka is the bilayer stretch coefﬁcient (12).
The binding of dN(S) curcumin molecules causes a change
in the energy dE ¼ eoSdNðSÞ1sASdNðSÞ; where the ﬁrst
term is the intrinsic binding energy, eoS; presumably due to
hydrophobic interaction, and the second term is the elasticity
energy of area stretching (or membrane thinning). Combining
this relation with Eq. 1, we obtain the energy level for the S
state (26):
ES ¼ eoS1 ðKa=2ÞðA2S=ALÞNðSÞ=L: (2)
The simplest choice for the energy level of the I state is a
constant EI ¼ eoI :Then the ratio of the numbers of curcumin
molecules in the S state and in the I state is NðSÞ=NðIÞ ¼
exp½bðES  EIÞ; with b1 ¼ kBT; the Boltzmann constant
times the temperature. From this we obtain the equation for
the ratio of curcumin molecules in the S state to all curcumin
molecules associated with themembrane,a[NðSÞ=Cb or for
x[aðCb=LÞ:
a ¼ 1
2
1 tan h bCb
L
a a
  
or
x
Cb=L
¼ 1
2
1 tan hðbx  aÞ½ ; (3)
where we have introduced Cb ¼ NðSÞ1NðIÞ; a ¼ bðeoS 
eoI Þ=2 and b ¼ bKaðA2S=ALÞ=4: Note that the only unknown
in b is AS. Ka ﬃ 243mN=m has been measured (12). AL ¼
73:4 A˚
2
is calculated from the h of pure DOPC (26.8 A˚
obtained from PtP ¼ 36.8 A˚ (9)) and its chain volume per
lipid (984 A˚3) (27).
The membrane thinning data Dh/h vs. Cb/L is interpreted
as x vs. Cb/L by rewriting Eq. 1 as
Dh=h ¼ ðAS=ALÞðCb=LÞa ¼ ðAS=ALÞx: (4)
Thus we can directly compare the solution of our model,
Eq. 3, with the data. We ﬁrst select two points in the data to
determine the two unknown constants a and b. We assume
FIGURE 4 Fractional thickness change of DOPC bilayer as a function of
curcumin content, expressed as bound curcumin/lipid molar ratio Cb/L. The
data are from Hung et al. (9). Two arrows indicate the points that were used
to determine two constants a and b in the model equation (Eq. 3). The solid
curve is the model prediction Dh/h (Eq. 4) from the solution of Eq. 3.
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that the initial binding is to the S state, i.e., a/1 asCb=L/0:
So the initial slope of Dh/h vs. Cb/L equals AS=AL (this
required a continuous curve ﬁtting to the data). This gives
AS ¼ 330 A˚2; and b ¼ 218: Next we ﬁnd the point of inter-
section between the line x ¼ ð1=2ÞCb=L and the data curve x
vs. Cb/L. At this point of intersection, called x1=2; the relation
bx1=2 ¼ a is satisﬁed (see Eq. 3). From the value of intersec-
tion x1=2; 0:005 and the value of b, we obtained a ¼ 1:1:
With a and b determined, we then solved Eq. 3 for a or x
and used Eq. 4. to reproduce Dh/h as a function of Cb/L. The
solution is compared with the data in Fig. 4; the agreement of
the model with the data is excellent.
We note that if we were to assume that ES is a constant, not
including the elastic energy of membrane thinning, then a
would be a constant and x would be proportional to Cb/L.
Then by Eq. 4, Dh/h vs. Cb/L would be a straight line,
strongly disagreeing with the data.
Membrane area expansion
Our model also predicts what to expect from the membrane
area expansion experiment. Since the initial membrane
thinning was due to curcumin initially bound mostly to the S
state, the area expansion should be DA=A; Dh=h for the
low Cb/L region. As the binding to the I state increased, the
area expansion DA=A should become larger than Dh=h:
This is because in our model we assume that curcumin in the I
state would cause area expansion but no thickness change.
In each of our GUV experiments, the vesicle projection
inside the micropipette was observed to reach an equilibrium
length. From this equilibrium length, we calculated the ﬁnal
fractional area expansion DA/A as a function of curcumin
concentration in solution. To compare with the membrane
thinning measurement, we will need to know the amount of
curcumin bound to the GUV at each curcumin concentration.
This was achieved by using the partition coefﬁcient from
solution to lipid bilayers measured previously by isothermal
titration calorimetry (9): Cb=L ¼ KCf ; K ¼ 2.4 3 104 M1,
where Cf is the curcumin concentration in solution. In Fig. 5,
DA/Awas plotted as a function ofCb/L for the upper and lower
limit measurements. The bottom curve shows the equivalent
fractional area expansion ðDA=AÞDh=h ¼ Dh=h from the
fractional thinning data shown in Fig. 4. Since ðDA=AÞDh=h
does not include the area expansion due to the curcumin in the
I state, it is smaller than the total area expansion that falls
somewhere between the upper and lower limits.
Note that the curcumin/lipid ratios Cb/L of the x-ray data
(the bottom curve of Fig. 5) were accurate because the cur-
cumin concentrations in the experimental samples for x-ray
diffraction were directly measured spectroscopically (9). In
contrast, theCb/L for the GUV experiment had an uncertainty
of approximately 610% (due to curcumin’s tendency to
adsorb to the containers’ walls; see Sample preparation). This
uncertainty in concentration made the GUV experiment un-
suitable in low Cb/L regions (,0.03) (due to the very large
slope in DA/A vs. Cb/L). Nevertheless, the GUV results
presented in Fig. 5 unambiguously conﬁrmed the two-state
model described in the last section.
The fractional area expansion by the two-state model is
given by
DA=A ¼ ðAS=ALÞðCb=LÞa1 ðAI=ALÞðCb=LÞð1 aÞ
¼ ðDA=AÞDh=h1 ðAI=ALÞðCb=LÞð1 aÞ: (5)
Since a is already determined by Eq. 3, the model allows
only one undetermined parameter AI for the GUV results. In
Fig. 5, we used Eq. 5 and different values of AI (12 A˚
2 and
6 A˚2, respectively) to ﬁt the upper and lower limits of the
curcumin effect (the top two curves). The real effect is in
between these two limits. It is clear that the measured
membrane area expansion by curcumin binding is consistent
with the two-state model. Eq. 5 predicted that at small values
of Cb/L where a is close to 1 (e.g., Cb/L ¼ 0.032), the frac-
tional area expansion of GUV should be close to the value of
(DA/A)Dh/h, and at larger values of Cb/L (.0.032) where a is
signiﬁcantly smaller than 1, the fractional area expansion of
GUV should be larger than the value of (DA/A)Dh/h. Both
features were born out by the GUV experiment. The agree-
ment also strongly supports the proposed sites for the two
states, one on the interface and another inserted in the hydro-
carbon region. The interfacial binding both thins the mem-
brane and expands the area, whereas the insertion among the
chains expands the area but has little thinning effect.
The monolayer area expansion per curcumin is AS; 330
A˚2 for the S state, and AI is between 6 A˚
2 and 12 A˚2 for the I
state. These values are not to be interpreted as the physical
dimensions of the curcumin molecule. (The largest and
smallest cross sections of curcumin molecular crystal are
roughly 122 A˚2 and 22 A˚2, respectively; 28.) A lipid bilayer
FIGURE 5 Fractional area expansion measured by GUV experiments
(squares and triangles) compared with the values corresponding to the
membrane-thinning measurement by x-ray (solid circles). The square and
triangle data are the asymptotic values DA/A taken from the lower and upper
limit measurements in Fig. 3, respectively; the error bars represent the
standard deviations. The real area expansion effect of curcumin falls between
the upper and lower limits. The curves are the results from the model as
explained in the text.
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is not an inert matrix to which a molecule binds. Rather it is a
complex assembly of ﬂexible lipid molecules and water
molecules. When a molecule binds to the lipid bilayer, the
molecule might bring in additional water molecules or release
some water molecules associated with the bilayer before
binding. Such a redistribution of water molecules would af-
fect the value of area expansion by molecular binding. For
example, the helical lengthwise cross section of melittin is
;400 A˚2, but the measured AS for melittin is only 175–246
A˚2, depending on the lipid compositions (26).
CONCLUSION
Curcumin binding to lipid bilayers follows the same binding
pattern of amphipathic peptides (26). Both curcumin and
peptides initially bind to the interface and then at higher
concentrations gradually partition to a state inserted into the
hydrocarbon region. The main difference is that curcumin
binds in both states as monomers (Eq. 3 is valid only for
monomers). On the other hand, amphipathic peptides bind to
the interface as monomers but insert into the hydrocarbon
region to form pores, each composed ofmultiple peptides (29).
Although curcumin and antimicrobial peptides are both am-
phipathic molecules, curcumin is far more hydrophobic than
the peptides (for example, magainin, 23 amino acids, carries
15 charges). Yet their binding behaviors to lipid bilayers are
basically the same. This suggests that the two-state binding of
curcumin to lipid bilayers is typical of amphipathic drugs.
The combination of the x-ray experiment for membrane
thickness and the GUV experiment for membrane area allows
us to determine the numerical values for the relative binding
energy eoS  eoI and area expansions per molecule AS and AI.
These values are important for quantitative understanding of
interactions with membranes, such as molecular dynamics
simulations. Also, the validity of both experimental results is
reinforced by mutual agreement.
Drug binding alters the physical properties of the lipid
bilayer, including a decrease of the hydrocarbon thickness
and softening of its elastic rigidity (2,9). Functions of some
membrane proteins have been shown to depend on such
physical properties of their host lipid bilayers, for example,
mechanosensitive channels (30) and gramicidin channels (2).
The result reported here suggests the possibility that drugs
inﬂuence functions of membrane proteins via their interac-
tions with lipid bilayers.
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